Medicare Enrolled
Dr. Azat Bogikian, M.D.
Family Medicine · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bogikian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bogikian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bogikian
Dr. Azat Bogikian is a family medicine specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bogikian performed 4,285 Medicare services across 1,107 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bogikian received a total of $18,686 from 59 pharmaceutical and/or device companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bogikian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in CA
$18,686 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,285
Medicare services
Top 4% in CA for family medicine
1,107
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~226 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,920 | $72 | $120 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
358 | $1 | $25 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
230 | $61 | $125 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
181 | $45 | $135 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
157 | $12 | $46 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 66 | $20 | $55 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
66 | $33 | $35 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
56 | $154 | $300 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
52 | $12 | $65 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
47 | $78 | $155 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
41 | $54 | $134 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
40 | $35 | $135 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $82 | $105 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
18 | $41 | $95 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
15 | $33 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,686
Total received (2018-2024)
Avg $2,669/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
687
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,686 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,514
2023
$1,948
2022
$1,898
2021
$2,770
2020
$2,210
2019
$3,093
2018
$4,254
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$359
Novo Nordisk Inc
$347
Lilly USA, LLC
$329
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$180
Xeris Pharmaceuticals, Inc.
$172
Sumitomo Pharma America, Inc.
$142
Lundbeck LLC
$100
Otsuka America Pharmaceutical, Inc.
$83
AstraZeneca Pharmaceuticals LP
$78
Ardelyx, Inc.
$72
Esperion Therapeutics, Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$52
SHIELD THERAPEUTICS INC
$45
Exact Sciences Corporation
$35
AIMMUNE THERAPEUTICS, INC.
$29
Merck Sharp & Dohme LLC
$28
IRONWOOD PHARMACEUTICALS, INC
$25
VIVUS LLC
$24
Alvogen Inc
$23
Kowa Pharmaceuticals America, Inc.
$23
Athena Bioscience, LLC
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
GlaxoSmithKline, LLC.
$19
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$5,050
Amgen Inc.
$2,192
Lilly USA, LLC
$1,348
Boehringer Ingelheim Pharmaceuticals, Inc.
$910
Amarin Pharma Inc.
$890
Astellas Pharma US Inc
$791
PFIZER INC.
$566
Takeda Pharmaceuticals U.S.A., Inc.
$549
AstraZeneca Pharmaceuticals LP
$448
Radius Health, Inc.
$418
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$416
GlaxoSmithKline, LLC.
$317
ARBOR PHARMACEUTICALS, INC.
$310
SANOFI-AVENTIS U.S. LLC
$246
Ironwood Pharmaceuticals, Inc
$228
Merck Sharp & Dohme Corporation
$223
Abbott Laboratories
$220
Esperion Therapeutics, Inc.
$217
Xeris Pharmaceuticals, Inc.
$217
Merck Sharp & Dohme LLC
$215
Sumitomo Pharma America, Inc.
$182
AbbVie Inc.
$165
IDORSIA PHARMACEUTICALS US INC
$160
Novartis Pharmaceuticals Corporation
$150
Nestle HealthCare Nutrition Inc.
$139
Arbor Pharmaceuticals, Inc.
$126
Lundbeck LLC
$126
Dexcom, Inc.
$120
Kowa Pharmaceuticals America, Inc.
$118
IRONWOOD PHARMACEUTICALS, INC
$115
Intuitive Surgical, Inc.
$107
Allergan Inc.
$106
Shield Therapeutics Inc
$102
Regeneron Healthcare Solutions, Inc.
$95
Medicure Pharma Inc.
$92
Otsuka America Pharmaceutical, Inc.
$83
Ardelyx, Inc.
$72
ABBVIE INC.
$67
Bayer Healthcare Pharmaceuticals Inc.
$67
MannKind Corporation
$64
AbbVie, Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$57
Boston Scientific Corporation
$52
E.R. Squibb & Sons, L.L.C.
$50
SHIELD THERAPEUTICS INC
$45
Avanir Pharmaceuticals, Inc.
$41
Janssen Pharmaceuticals, Inc
$40
Sunovion Pharmaceuticals Inc.
$40
Vertiflex, Inc.
$37
Exact Sciences Corporation
$35
IBSA Pharma Inc.
$31
AIMMUNE THERAPEUTICS, INC.
$29
VIVUS LLC
$24
Alvogen Inc
$23
Athena Bioscience, LLC
$20
Allergan, Inc.
$20
West-Ward Pharmaceuticals
$18
Eisai Inc.
$18
GENZYME CORPORATION
$16
Top 3 companies account for 46.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · ANORO · Aimovig · BAQSIMI · BASAGLAR · BELSOMRA · BREZTRI · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · Creon · DEXCOM G7 GSS (161) · DUPIXENT · DUZALLO · Da Vinci Surgical System · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FORTEO · FreeStyle Libre · FreeStyle Libre Pro · GEMTESA · GVOKE HYPOPEN · HMG-CoA reductase inhibitor. · Horizant · IBSRELA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYRICA · LYUMJEV · Licart · Linzess · Livalo · MOTEGRITY · MOUNJARO · MYRBETRIQ · Mitigare · Motegrity · Myrbetriq · NAMZARIC · NEXICLON XR · NEXLETOL · NUEDEXTA · Otezla · Ozempic · PANCREAZE · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SUPERION · SYMBICORT · SYNTHROID · Superion ISS · TERIPARATIDE · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · Tymlos · VERQUVO · VIBERZI · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZENPEP · ZORYVE · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
2,881
Per 100K population
29.3
County median income
$87,760
Nearest hospital
USC VERDUGO HILLS HOSPITAL
1.4 mi
1.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bogikian is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bogikian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Bogikian performed 2,920 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bogikian receive payments from pharmaceutical companies?
Yes. Dr. Bogikian received a total of $18,686 from 59 companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bogikian's costs compare to other family medicine physicians in Glendale?
Dr. Bogikian's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bogikian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Glendale
Browse family medicine physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology